메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

ESG

ESG

Technological Impact

Acceleration of Development Process

Accelerating drug discovery and development processes
through a GenAI-powered genome mining platform.

Paradigm Shift

Developing rapid and broad-spectrum therapeutics
that overcome the limitations of conventional vaccines against emerging viruses.

Social Impact

Securing Domestic &
Global Market Leadership

Establishing microbiome R&D capabilities and infrastructure
to provide innovative products and personalized healthcare solutions.

Minimizing Social Disruption

Minimizing social unrest caused by pandemics
through the rapid development of treatments for emerging infectious diseases.

Social Contribution

Contributing to global public health by addressing rotavirus-induced
infant infections in developing countries (Promoting Health ODA with UNICEF and WHO).

Economic Impact

Market Growth

Expanding the medifood market through GenAI-driven functional materials
and generating high revenue through differentiated,
high-value-added innovative drug development.

Creating Future Growth Engines

Expanding global market share beyond the domestic market
by developing a diverse range of premium medifood products.

ESG Management

Promoting environmental protection and social responsibility
through sustainable ingredient sourcing and health improvement.